OSEC

Neohapsis is currently accepting applications for employment. For more information, please visit our website www.neohapsis.com or email hr@neohapsis.com
 
[SA11990] IBM Informix I-Spy "runbin" Privilege Escalation Vulnerability

From: Secunia Security Advisories (sec-advsecunia.com)
Date: Fri Jul 02 2004 - 03:50:09 CDT


TITLE:
IBM Informix I-Spy "runbin" Privilege Escalation Vulnerability

SECUNIA ADVISORY ID:
SA11990

VERIFY ADVISORY:
http://secunia.com/advisories/11990/

CRITICAL:
Less critical

IMPACT:
Privilege escalation

WHERE:
Local system

SOFTWARE:
IBM Informix I-Spy 2.x
http://secunia.com/product/3652/

DESCRIPTION:
A vulnerability has been discovered in IBM Informix I-Spy, which can
be exploited by malicious, local users to gain escalated privileges.

The problem is that the "runbin" tool erroneously is setuid "root",
which may grant unprivileged users "root" privileges on an affected
system.

SOLUTION:
The vulnerability will be fixed in versions 2.00.UD3 and 2.00.FD3.

IBM has provided a script, which addresses the issue (see
instructions in the original advisory):
http://www-1.ibm.com/support/docview.wss?uid=swg21172742&aid=1

PROVIDED AND/OR DISCOVERED BY:
Reported by vendor.

ORIGINAL ADVISORY:
http://www-1.ibm.com/support/docview.wss?uid=swg21172742&rs=260

----------------------------------------------------------------------

About:
This Advisory was delivered by Secunia as a free service to help
everybody keeping their systems up to date against the latest
vulnerabilities.

Subscribe:
http://secunia.com/secunia_security_advisories/

Definitions: (Criticality, Where etc.)
http://secunia.com/about_secunia_advisories/

Please Note:
Secunia recommends that you verify all advisories you receive by
clicking the link.
Secunia NEVER sends attached files with advisories.
Secunia does not advise people to install third party patches, only
use those supplied by the vendor.

----------------------------------------------------------------------

Unsubscribe: Secunia Security Advisories

----------------------------------------------------------------------